| Personal benefit |
|
| No perceived personal benefit from testing |
Halbert et al. (2017), Mayo-Gamble et al. (2019), Miller, (2020), Nooruddin et al. (2020), Umeukeje et al. (2019)
|
| Insufficient compensation for research participation |
Nooruddin et al. (2020)
|
| Burdens of Testing |
|
| Requires giving blood |
Nooruddin et al. (2020), Ochs-Balcom et al. (2011)
|
| Requires visit to specialist or research location |
Armstrong et al. (2012), McDonald et al. (2014)
|
| Time |
Nooruddin et al. (2020), Ochs-Balcom et al. (2011), Parikh et al. (2019)
|
| Cost |
Bevan et al. (2003), Gordon et al. (2017), Gordon, Amórtegui, et al., 2019, Gordon, Amórtegui, et al., 2019, Gordon, Wicklund, et al., 2019, Mayo-Gamble et al. (2019), Miller, (2020), Myers et al. (2000)
|
| Access to and Use of Results |
|
| Future insurance discrimination |
Armstrong et al. (2012), Bevan et al. (2003), Gordon et al. (2017), Gordon et al. (2018), Gordon, Amórtegui, et al., 2019, Gordon, Amórtegui, et al., 2019, Gordon, Wicklund, et al., 2019
|
| Loss of confidentiality |
Bevan et al. (2003), McDonald et al. (2014), Myers et al. (2000), Ochs-Balcom et al. (2011)
|
| Misuse of information |
Gordon, Amórtegui, et al., 2019, Gordon, Amórtegui, et al., 2019, Gordon, Wicklund, et al., 2019, Nooruddin et al. (2020)
|
| Financial impact of results |
Gordon et al. (2018), Halbert, Gandy Jr, et al. (2006), Halbert, Kessler, et al., 2006, Miller, (2020)
|
| Psychological harm from results |
Gordon et al. (2018), Halbert, Gandy Jr, et al., 2006, Halbert, Kessler, et al. (2006), Myers et al. (2000), Umeukeje et al. (2019)
|
| Harm to others |
Gordon et al. (2018), Umeukeje et al. (2019)
|
| Stigma |
Gordon et al. (2018), Gordon, Amórtegui, et al., 2019, Gordon, Amórtegui, et al., 2019, Gordon, Wicklund, et al., 2019
|
| Discrimination |
Bevan et al. (2003), Halbert, Gandy Jr, et al. (2006), Halbert, Kessler, et al. (2006), Halbert et al. (2017), Powell-Young and Spruill (2013), Umeukeje et al. (2019)
|
| Trust |
|
| Fear being used as lab rat |
Gordon, Amórtegui, et al., 2019, Gordon, Amórtegui, et al., 2019, Gordon, Wicklund, et al., 2019
|
| Mistrust of scientists or healthcare system |
Armstrong et al. (2012), Gordon et al. (2018), Gordon, Amórtegui, et al., 2019, Gordon, Amórtegui, et al., 2019, Gordon, Wicklund, et al., 2019, Kikut et al. (2020), Miller, (2020), Nooruddin et al. (2020), Ochs-Balcom et al. (2011), Umeukeje et al. (2019)
|
| Questionable reliability of science and results |
Halbert, Gandy Jr, et al. (2006), Halbert, Kessler, et al. (2006), Miller, (2020)
|
| Required to give DNA |
Nooruddin et al. (2020), Parikh et al. (2019)
|
| Race |
|
| Genetic ancestry verus race or culture - lack of clarity about who truly is at risk |
Bevan et al. (2003), Gordon, Amórtegui, et al., 2019, Gordon, Amórtegui, et al., 2019, Gordon, Wicklund, et al., 2019, Miller, (2020)
|
| Racial profiling |
Gordon et al. (2017)
|
| Universal testing is more appropriate than race-based testing |
Bevan et al. (2003), Gordon, Amórtegui, et al., 2019, Gordon, Amórtegui, et al., 2019, Gordon, Wicklund, et al., 2019, Mayo-Gamble et al. (2019)
|
| Race-specific marketing |
Armstrong et al. (2012), McDonald et al. (2014)
|
| Communication and Information Needs |
|
| Little discussion of disease within families or community |
Mayo-Gamble et al. (2019), Ochs-Balcom et al. (2011)
|
| Poor physician knowledge or communication |
Mayo-Gamble et al. (2019)
|
| Lack knowledge about genetics or research |
Halbert et al. (2017), Mayo-Gamble et al. (2019), Ochs-Balcom et al. (2011)
|
| Lack of clarity about what test results mean for individual |
Gordon et al. (2018), Gordon, Amórtegui, et al., 2019, Gordon, Amórtegui, et al., 2019, Gordon, Wicklund, et al., 2019, Horowitz et al. (2016)
|
| Uncertainty about what it means to be at risk |
Gordon, Amórtegui, et al., 2019, Gordon, Amórtegui, et al., 2019, Gordon, Wicklund, et al., 2019, Horowitz et al. (2016)
|
| Overall need for more health and genetic information |
Gustafson et al. (2007), Horowitz et al. (2016), Miller, (2020)
|
| Lack of clarity about how African American identity is connected to APOL1 variants |
Gordon et al. (2018)
|
| Need for more community education and improved communication regarding APOL1 and SC |
Mayo-Gamble et al. (2019), Umeukeje et al. (2019), Young et al. (2019)
|
| Clinicians' Concerns |
|
| Tests of unknown significance |
Koraishy et al. (2018)
|
| Cost |
Koraishy et al. (2018)
|
| Uncomfortable using race in testing/ethical concerns with testing |
Horowitz et al. (2014), Koraishy et al. (2018)
|
| Feel ill-prepared to address genetics |
Horowitz et al. (2014), Horowitz et al. (2016), Powell-Young and Spruill (2013)
|
| Testing could result in discrimination against minorities |
Powell-Young and Spruill (2013)
|